GLP1R and synucleinopathy: GLP-1R agonism can reverse neuronal toxicity linked to synucleinopathy by decreasing oxidative stress, enhancing mitochondrial and lysosomal function, reducing α-synuclein aggregation, and improving neuronal survival.